#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis Ureteric cancer Mantle cell lymphoma recurrent Meningococcal immunisation Pancreatic neuroendocrine tumour Hodgkin's disease Hyperinsulinism Sjogren's syndrome Follicular lymphoma stage I Adenocarcinoma pancreas Noonan syndrome Cutaneous lupus erythematosus Depression Immunodeficiency congenital Encephalitis autoimmune More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Trials in Disease Medulloblastoma – Trials in Disease Burkitt’s lymphoma – Treatment Leukoencephalopathy – Trials in Disease Alport’s syndrome – Trials in Disease Biotinidase deficiency Congenital nephrogenic diabetes insipidus – Basic Information Langerhans’ cell histiocytosis – Basic Information Focal segmental glomerulosclerosis – Diagnostics Hyperoxaluria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Cancellous Bone Cpk850 Tolcapone Zinc Acetate Dihydrate Tocotrienol Vortioxetine Rifaximin 2-DEOXY-D-GLUCOSE VHB937 Setanaxib Anitocabtagene Autoleucel Dacarbazine Citrate Asciminib Hydrochloride Gsk4532990A IBUZATRELVIR Relacorilant Mirvetuximab Soravtansine NORGESTIMATE Pyridoxine Hydrochloride Bp Brexpiprazole Fumarate More therapies…

    Learn about Your Condition

    Head injury Red blood cell abnormality Glanzmann's disease Lichen sclerosus Brain injury Hypothyroidism Osteonecrosis of jaw Thyroid disorder Vulvovaginal candidiasis Urea cycle disorder Frontotemporal dementia Food allergy Chorioretinitis Systemic mastocytosis Renal cell carcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Tovorafenib
    • Vinblastine Sulfate
    • Carboplatin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn’s Disease and an Ileostomy

    Not recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Azd7798
    Belgium Italy The Netherlands Poland Sweden

  • Study on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment

    Not recruiting

    3 1 1 1
    France Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pegcetacoplan
    Austria Germany Italy The Netherlands

  • Study on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Canagliflozin
    • Dapagliflozin
    • Empagliflozin
    Italy

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4

  • Study on Switching from Boosted Protease Inhibitors to Fostemsavir for People with HIV-1 with Limited Treatment Options

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Fostemsavir Trometamol
    Italy Spain

  • Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

    Not recruiting

    3 1 1
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    Czechia Denmark France Germany Italy The Netherlands +4

  • Long-term Study on the Safety and Effectiveness of Odevixibat for Patients with Alagille Syndrome

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Odevixibat
    Belgium France Germany Italy The Netherlands Poland
Previous Page
1 … 28 29 30 31 32 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!